Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry

Cancer

Volumn 101, Issue 9, 2004, Pages 2006-2010

  Cheng, Liang ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomarker; Chemotherapy; Germ cell tumors; Metastasis; Neoplasia; OCT4; Testis; Unknown primary tumor

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BLADDER TUMOR; CHORIOCARCINOMA; COLON CANCER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; NEUROECTODERM TUMOR; PANCREAS CANCER; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE TUMOR; PROTEIN EXPRESSION; SEMINOMA; STOMACH CANCER; TERATOMA; YOLK SAC TUMOR;

ANTIGENS, CD30; DNA-BINDING PROTEINS; GERMINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OCTAMER TRANSCRIPTION FACTOR-3; TESTICULAR NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 7044226225     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20566     Document Type: Article

References (45)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:5-29.
2. Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol. 1990;8:1777-1781.
3. Ulbright TM. Testis risk and prognostic factors. The pathologist's perspective. Urol Clin North Am. 1999;26:611-626.
4. Scholer HR, Dressler GR, Balling R, Rohdewohld H, Gruss P. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 1990;9:2185-2195.
5. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell. 1990;60:461-472.
6. Rosner MH, Vigano MA, Ozato K, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature. 1990;345:686-692.
7. Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod. 2000;6:999-1004.
8. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379-391.
9. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372-376.
10. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244-2250.
11. Ulbright TM, Amin MB, Young RH. Tumors of the testis, adnexa, spermatic cord, and scrotum. Washington, DC: Armed Forces Institute of Pathology, 1999.
12. Cheng L, Leibovich BC, Bergstralh EJ, et al. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer. 1999;85:2455-2459.
13. Cheng L, Lloyd RV, Weaver AL, et al. The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res. 2000;6:1896-1899.
14. Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG. E-cadherin expression in primary and metastatic prostate cancer. Am J Pathol. 1996;148:1375-1380.
15. Cheng L, Pan C, Zhang JT, et al. Loss of 14-3-3σ in prostate cancer and its precursors. Clin Cancer Res. 2004;10:3064-3068.
16. Cheng L, Sebo TJ, Cheville JC, et al. P53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cancer. 1999;85:1293-1299.
17. Cheng L, Thomas A, Roth LM, Zheng WM, Michael H, Abdul-Karim FW. OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol. In press.
18. Cheng L, Pisansky TM, Sebo TJ, et al. Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression. Clin Cancer Res. 1999;5:2820-2823.
19. Pan CX, Kinch MS, Kiener PA, et al. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Clin Cancer Res. 2004;10:1333-1337.
20. Zeng G, Hu Z, Kinch MS, et al. High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia. Am J Pathol. 2003;163:2271-2276.
21. Jiang J, Neubauer BL, Graff JR, et al. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol. 2002;160:667-671.
22. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L. OCT4 is a sensitive and specific marker for testicular seminoma and embryonal carcinoma. Am J Surg Pathol. 2004;28:935-940.
23. Comiter CV, Renshaw AA, Benson CB, Loughlin KR. Burned-out primary testicular cancer: sonographic and pathological characteristics. J Urol. 1996;156:85-88.
24. Powell S, Hendry WF, Peckham MJ. Occult germ-cell testicular tumours. Br J Urol. 1983;55:440-444.
25. Moertel CG, Reitemeier RJ, Schutt AJ, Hahn RG. Treatment of the patient with adenocarcinoma of unknown origin. Cancer. 1972;30:1469-1472.
26. Hillen HF. Unknown primary tumors. Postgrad Med J. 2000;76:690-693.
27. Hamilton-Dutoit SJ, Lou H, Pallesen G. The expression of placental alkaline phosphatase (FLAP) and PLAP-like enzymes in normal and neoplastic human tissues. An immunohistological survey using monoclonal antibodies. APMIS. 1990;98:797-811.
28. Epenetos AA, Travers P, Gatter KC, Oliver RD, Mason DY, Bodmer WF. An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase. Br J Cancer. 1984;49:11-15.
29. Nouwen EJ, Hendrix PG, Dauwe S, Eerdekens MW, De Broe ME. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. Am J Pathol. 1987;126:230-242.
30. Nouwen EJ, Pollet DE, Eerdekens MW, Hendrix PG, Briers TW, De Broe ME. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res. 1986;46:866-876.
31. Nouwen EJ, Pollet DE, Schelstraete JB, et al. Human placental alkaline phosphatase in benign and malignant ovarian neoplasia. Cancer Res. 1985;45:892-902.
32. Shikata H, Noguchi M, Utsumi N, et al. Immunoperoxidase investigation of Regan isoenzyme of alkaline phosphatase in maxillary sinus carcinomas. Oral Surg Oral Med Oral Pathol. 1986;61:356-361.
33. Skinner JM, Whitehead R. Carcinoplacental alkaline phosphatase in malignant and premalignant conditions of the human digestive tract. Virchows Arch A Pathol Anat Histol. 1981;394:109-118.
34. Wick MR, Swanson PE, Manivel JC. Placental-like alkaline phosphatase reactivity in human tumors: an immunohistochemical study of 520 cases. Hum Pathol. 1987;18:946-954.
35. Sunderland CA, Davies JO, Stirrat GM. Immunohistology of normal and ovarian cancer tissue with a monoclonal antibody to placental alkaline phosphatase. Cancer Res. 1984;44:4496-4502.
36. Pallesen G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol. 1988;133:446-450.
37. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985;66:848-858.
38. Polski JM, Janney CG. Ber-H2 (CD30) immunohistochemical staining in malignant melanoma. Mod Pathol. 1999;12:903-906.
39. Suster S, Moran CA, Dominguez-Malagon H, Quevedo-Blanco P. Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases. Hum Pathol. 1998;29:737-742.
40. Berney DM, Shamash J, Pieroni K, Oliver RT. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy? Histopathology. 2001;39:382-385.
41. Bosl GJ, Dmitrovsky E, Reuter VE, et al. Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst. 1989;81:1874-1878.
42. Chaganti RSK, Houldsworth J. Genetics and biology of adult human male germ cell tumors. Cancer Res. 2000;60:1475-1482.
43. Looijenga LHJ, Oosterhuis JW. Pathogenesis of testicular germ cell tumours. Rev Reprod. 1999;4:90-100.
44. Guillaudeux T, Mattel MG, Depetris D, Le Bouteiller P, Pontarotti P. In situ hybridization localizes the human OTF3 to chromosome 6p21.3→p22 and OTF3L to 12p13. Cytogenet Cell Genet. 1993;63:212-214.
45. Saijoh Y, Fujii H, Meno C, et al. Identification of putative downstream genes of Oct-3, a pluripotent cell-specific transcription factor. Genes Cells. 1996;1:239-252.